LexisNexis® Legal Newsroom
Zoloft® & SSRIs: The Plaintiffs’ Perspective - An HB Law & Science Conference Report

Two major classes of drugs recently have been the subject of mass tort litigation for their alleged tendency to cause birth defects. The first group includes Topamax® and Topiramate, used to treat migraines, and the second comprises Zoloft® and the other Selective Serotonin Reuptake Inhibitor...

$4 Million Awarded In 1st Pa. Trial Alleging Birth Defect From Topamax Epilepsy Drug

PHILADELPHIA — (Mealey’s) A Pennsylvania jury on Oct. 30 found that Janssen Pharmaceuticals Inc. failed to warn about the risk of birth defects from its Topamax epilepsy drug and awarded the injured minor $4 million in damages (April Czimmer, et al. v. Ortho-McNeil-Janssen Pharmaceutica,...

Pennsylvania State Court Jury Awards $10 Million In 2nd Topamax Birth Defect Trial

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Nov. 18 awarded more than $10 million to a family whose son was born with a cleft palate allegedly caused by his mother’s use of the antiepileptic drug Topamax during pregnancy, according to one of the law firms representing...

Janssen Settles Some Pa. Topamax Birth Defect Cases, Will Appeal $3M Verdict

PHILADELPHIA — (Mealey’s) Topamax manufacturer Janssen Pharmaceuticals on March 10 said it will appeal a $3 million March 7 birth defect verdict in the Philadelphia County Common Pleas Court even though it reached an agreement to resolve a number of similar cases in the state court, including...